A novel antagonist of Toll-like receptors 7, 8 and 9 suppresses lupus disease-associated parameters in NZBW/F1 mice (Q44175614)

30 November 2017

A novel antagonist of Toll-like receptors 7, 8 and 9 suppresses lupus disease-associated parameters in NZBW/F1 mice (English)

1 reference

30 November 2017

0 references

Fu-Gang Zhu

1

1 reference

30 November 2017

Weiwen Jiang

2

1 reference

30 November 2017

Lakshmi Bhagat

3

1 reference

30 November 2017

Daqing Wang

4

1 reference

30 November 2017

Dong Yu

5

1 reference

30 November 2017

Jimmy X Tang

6

1 reference

30 November 2017

Ekambar R Kandimalla

7

1 reference

30 November 2017

Nicola La Monica

8

1 reference

30 November 2017

Sudhir Agrawal

9

1 reference

30 November 2017

12 June 2013

1 reference

30 November 2017

1 reference

30 November 2017

46

1 reference

30 November 2017

7

1 reference

30 November 2017

419-428

1 reference

Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data

30 November 2017

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

Understanding the epidemiology and progression of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

Systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

Treatment of systemic lupus erythematosus: new advances in targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

Belimumab: a BLyS-specific inhibitor for the treatment of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

Lupus: novel therapies in clinical development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

Regulation of autoreactive B cell responses to endogenous TLR ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

RAGE-independent autoreactive B cell activation in response to chromatin and HMGB1/DNA immune complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

Dendritic cells in lupus are not required for activation of T and B cells but promote their expansion, resulting in tissue damage

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

Toll-like receptors in systemic autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

Endogenous type I interferon inducers in autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

The interferon-alpha signature of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

The type I interferon system in the development of lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

Type I interferons in systemic autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

Inhibition of murine macrophage IL-12 production by natural and synthetic DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

Optimal oligonucleotide sequences for TLR9 inhibitory activity in human cells: lack of correlation with TLR9 binding

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

Classification, mechanisms of action, and therapeutic applications of inhibitory oligonucleotides for Toll-like receptors (TLR) 7 and 9.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

G-rich DNA suppresses systemic lupus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Fas(lpr/lpr) mice in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

Treatment with a toll-like receptor inhibitory GpG oligonucleotide delays and attenuates lupus nephritis in NZB/W mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleotides at a site proximal to NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

Oligodeoxyribonucleotide-based antagonists for Toll-like receptors 7 and 9.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

Pathogenesis of the glomerulonephritis of NZB/W mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

The innate immune system in SLE: type I interferons and dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

Dysregulation of T helper cell cytokines in autoimmune prone NZB x NZW F1 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

The role of interleukin-10 in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

Inflammasomes and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

Tumor necrosis factor-alpha antagonist etanercept decreases blood pressure and protects the kidney in a mouse model of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

Oxidative stress in systemic lupus erythematosus: relationship to Th1 cytokine and disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

Human Toll-like receptor 8 can be cool too: implications for foreign RNA sensing

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

Toll-like receptors and human disease: lessons from single nucleotide polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

Current and novel therapeutics in the treatment of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

The antiphospholipid syndrome and SLE: is there a clue in the link between complement and coagulation?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

Suppressive oligodeoxynucleotides delay the onset of glomerulonephritis and prolong survival in lupus-prone NZB × NZW mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

Polimorphisms in Inflammasome Genes Are Involved in the Predisposition to Systemic Lupus Erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08916934.2013.798651

10.3109/08916934.2013.798651

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference